Everything you need to know about ranked-choice voting in one spot. Click to learn more!

Arizona Proposition 303, Medical Product Authorization for Terminally Ill Patients Initiative (2014)

From Ballotpedia
Jump to: navigation, search
Arizona Proposition 303

Flag of Arizona.png

Election date

November 4, 2014

Topic
Healthcare
Status

ApprovedApproved

Type
Legislatively referred state statute
Origin

State legislature



Arizona Proposition 303 was on the ballot as a legislatively referred state statute in Arizona on November 4, 2014. It was approved.

A "yes" vote supported permitting drug and medical device manufacturers to make products available to terminally ill patients that have completed phase one of a clinical trial but have not yet been approved by the U.S. Food and Drug Administration.

A "no" vote opposed permitting drug and medical device manufacturers to make products available to terminally ill patients that have completed phase one of a clinical trial but have not yet been approved by the U.S. Food and Drug Administration.


Election results

Arizona Proposition 303

Result Votes Percentage

Approved Yes

1,111,850 78.47%
No 304,971 21.53%
Results are officially certified.
Source


Text of measure

Ballot title

The ballot title for Proposition 303 was as follows:

ENACTING AND ORDERING THE SUBMISSION TO THE PEOPLE OF A MEASURE RELATING TO THE USE OF INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS AND DEVICES.

Ballot summary

The ballot summary for this measure was:

ALLOWS A MANUFACTURER TO MAKE AVAILABLE TO AN ELIGIBLE TERMINALLY ILL PATIENT DRUG, BIOLOGICAL PRODUT OR DEVICE THAT HAS SUCCESSFULLY COMPLETED PHASE ONE OF A CLINICAL TRIAL BUT HAS NOT BEEN APPROVED FOR GENERAL USE BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION.

Full Text

The full text of this measure is available here.


Path to the ballot

A simple majority vote was needed in each chamber of the Arizona State Legislature to refer the measure to the ballot for voter consideration.

See also


External links

Footnotes